SAN FRANCISCO — In an era where technological disruption continually reshapes the boundaries of human capability, the intersection of design, healthcare, and artificial intelligence remains one of the most vital frontiers for innovation. Jules Sherman, celebrated as the winner of the prestigious 2025 National Design Award in Product Design, is set to headline an upcoming virtual lunchtime conversation that promises to explore this dynamic landscape. Hosted by design leaders and industry experts, the virtual event will feature Sherman reflecting on a transformative decade in her design practice. Drawing extensively from her pioneering work in medical device design and healthcare innovation, Sherman will trace the methodological evolution of her craft—moving from foundational, hand-drawn sketches to advanced, state-of-the-art artificial intelligence tools. Following her keynote presentation, Sherman will sit down for an intimate, in-depth conversation with Amber Bravo, head of Story Studio at Figma. The discussion will unpack the modern realities of design, focusing particularly on how AI acts as an accelerator for creative velocity, software integration, and the democratization of complex coding tools. This comprehensive report explores the main facts of the upcoming event, the compelling chronology of Sherman’s career, the supporting data and clinical impacts of her medical inventions, the broader implications of her human-centered design philosophy, and official perspectives shaping the future of product development. Main Facts: The Intersection of Design, Healthcare, and AI The upcoming virtual lunchtime event brings together two towering figures in contemporary design and technology: Jules Sherman and Amber Bravo. The Keynote Speaker: Jules Sherman is the recipient of the 2025 National Design Award in Product Design. Renowned for her work in pediatric and maternal healthcare innovation, Sherman’s career is defined by a shift from commercial consumer goods to life-saving, FDA-cleared medical devices. The Interlocutor: Amber Bravo leads Story Studio at Figma, where she shapes brand vision, product understanding, and storytelling strategy. With a deep background spanning Google’s Material Design, Herman Miller, Dwell, and The FADER, Bravo brings a profound cultural and strategic lens to the dialogue. The Core Themes: The discussion will center on how design practices have evolved over the last ten years, transitioning from traditional tactile sketching to AI-driven workflows. Furthermore, the speakers will examine what it truly means to design for vulnerable populations—specifically patients and their families—and how digital tools like Figma can streamline human-computer interaction (HCI) studies. The Technology Focus: A major portion of the conversation will tackle the role of artificial intelligence in supporting a designer’s need for speed, seamless software integration, and the reduction of traditional barriers to coding and software deployment. Chronology: A Decade of Transformation and Personal Catalyst To understand the weight of Sherman’s insights, one must look at the remarkable trajectory of her career—a journey catalyzed by personal experience and driven by a relentless commitment to human-centric problem-solving. 2010: The Catalyst In 2010, Jules Sherman experienced a traumatic hospital birth. Rather than letting the experience remain an isolated personal hardship, Sherman weaponized her professional background in consumer product design to interrogate the systemic shortcomings of maternal and pediatric healthcare. She recognized that while consumer electronics and lifestyle products enjoyed rapid, empathetic technological advancements, clinical environments often lagged behind in ergonomic and emotionally intelligent design. The Innovation Lab Era (2013–2023) For more than a decade, Sherman embedded herself within premier clinical innovation labs, notably at Stanford Medicine and Children’s National Hospital. In these high-stakes environments, she worked shoulder-to-shoulder with multidisciplinary teams comprising clinicians, biomedical engineers, and patient families. It was during this period that she transitioned from ideating conceptual medical devices to shepherding FDA-cleared products through rigorous clinical trials and commercialization. Concurrently, Sherman began imparting her knowledge to the next generation of innovators, teaching design-thinking methodologies for medical device development to clinical nurses, medical students, and bioengineering cohorts. Academic Pursuits and Current Inquiries Never one to rest on her laurels, Sherman expanded her academic footprint. As an adjunct professor at the University of Maryland, she integrated her real-world design methodologies into bioengineering curricula. Currently, Sherman is pursuing graduate studies in Human-Computer Interaction (HCI) at the University of California, Irvine (UCI). At UCI, she is actively developing specialized digital and physical projects tailored for pediatric care and mobile health clinic applications, bridging the gap between hardware engineering and software interfaces. Supporting Data: Innovations That Save Lives Sherman’s portfolio is not merely theoretical; it is marked by tangible, life-saving interventions deployed in neonatal intensive care units (NICUs) and pediatric wards across the country. Her work addresses critical vulnerabilities in infant and maternal care through rigorous adherence to safety, efficacy, and human factors engineering. Key Medical Inventions by Jules Sherman: Trach Sense: An innovative diagnostic and monitoring device designed to detect tracheostomy complications early, mitigating life-threatening respiratory obstructions in pediatric patients. The Kangarobe: A specialized garment engineered to optimize and encourage skin-to-skin care (kangaroo mother care) in high-stress neonatal ICU environments, promoting infant neurodevelopment and thermal regulation. Primo-Lacto: A thoughtfully designed, closed system for colostrum collection. This device addresses the severe hygienic and efficiency hurdles faced by new mothers attempting to harvest and preserve early breast milk in clinical settings. NOOMA Tech: A medical facilitation tool designed to streamline and ensure the efficacy of delayed cord clamping for preterm infants, a clinical practice proven to improve neonatal blood volume and reduce mortality. These devices reflect Sherman’s overarching design philosophy: that medical technology must be designed with the end-user—the clinician, the nurse, and the terrified parent—rather than simply imposed upon them from an insulated corporate laboratory. Official Responses and Strategic Perspectives The dialogue between Sherman and Bravo touches upon broader industry shifts regarding how design teams operate, communicate, and utilize emerging technologies. The Agency of AI in Modern Design Amber Bravo’s leadership at Figma’s Story Studio positions her at the bleeding edge of collaborative design software. Figma has become an indispensable digital ecosystem for modern creators, including scholars like Sherman who leverage the platform for advanced human-computer interaction studies. According to Bravo and industry observers, artificial intelligence is no longer viewed merely as a novelty or a threat to traditional artistry, but rather as an indispensable co-pilot. In a modern design environment characterized by compressed timelines and complex multi-platform requirements, AI serves to bridge functional divides. By lowering the barriers to entry for coding, prototyping, and software integration, AI allows designers to focus on what matters most: empathy, strategy, and human connection. Designing for the Human Heartbeat In her upcoming reflections, Sherman is expected to emphasize that technology and AI are only as valuable as the human empathy guiding them. Designing for patients and families requires an acute awareness of psychological trauma, emotional fatigue, and systemic medical bureaucracy. "When you design for a neonatal intensive care unit, you are not just designing for a doctor or an infant; you are designing for a mother who has just undergone trauma, a father who is overwhelmed, and a nurse who is managing twelve critical beds simultaneously," design advocates note regarding Sherman’s core ethos. By incorporating AI-driven rapid prototyping into this workflow, designers can iterate faster, test safety protocols more rigorously, and deliver intuitive solutions to the bedside with unprecedented speed. Implications: The Future of Product Design and Healthcare Innovation The convergence of Jules Sherman’s clinical innovations and Amber Bravo’s digital storytelling expertise carries profound implications for the future of multiple industries. 1. The Democratization of Technical Tools As AI continues to streamline coding and software integration, the traditional silos separating industrial designers, software engineers, and medical practitioners are beginning to dissolve. Designers are no longer required to spend years mastering arcane programming languages to bring a digital interface to life. This acceleration empowers creative practitioners to test ideas instantly, scaling innovations from a hand-drawn sketch to a functional prototype in days rather than months. 2. A New Standard for Human-Centered MedTech Sherman’s success—culminating in the 2025 National Design Award—signals a broader cultural shift within the design community. Aesthetics alone are no longer sufficient to claim top industry accolades. The market and professional bodies increasingly demand that product design serve a profound ethical, social, and clinical purpose. By centering her practice around maternal health, pediatric safety, and equitable healthcare access, Sherman has set a new benchmark for what it means to be a modern product designer. 3. Education and Interdisciplinary Collaboration As seen through her work at Stanford, Children’s National Hospital, the University of Maryland, and UC Irvine, the future of innovation lies in radical interdisciplinary education. By teaching design thinking to medical students and bioengineering principles to designers, the healthcare sector can cultivate a workforce uniquely equipped to tackle complex systemic challenges. Conclusion As Jules Sherman takes the virtual stage to reflect on a decade defined by hand-drawn sketches, clinical breakthroughs, and artificial intelligence, the design community stands at a fascinating crossroads. Through her conversation with Amber Bravo, attendees will gain a rare, behind-the-scenes look at how empathy and technology can successfully coalesce to solve humanity’s most sensitive problems. For aspiring designers, healthcare innovators, and technology leaders alike, Sherman’s journey offers a masterclass in resilience, purposeful creation, and the endless possibilities that emerge when human ingenuity is augmented by modern tools. To learn more about the National Design Awards and upcoming programming, visit the Cooper Hewitt National Design Awards official portal. Post navigation Invisible Architecture: How Biome Environmental Solutions Concealed Gamaya Farms within the Indian Landscape The Invisible Web: Why the Death of the "Click" is the Future of Design
